The Use of Rapid Coverage Monitoring in the National Rubella Vaccination Campaign, Haiti 2007–2008

Background. Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles immunization campaign targeting persons 1–19 years of age to accelerate elimination of rubella and congenital rubella syndrome, while stre...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 204; no. suppl_2; pp. S698 - S705
Main Authors Lacapère, François, Magloire, Roc, Danovaro-Holliday, M. Carolina, Flannery, Brendan, Chamoulliet, Henriette, Celestin, Elie-Pierre
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.09.2011
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background. Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles immunization campaign targeting persons 1–19 years of age to accelerate elimination of rubella and congenital rubella syndrome, while strengthening measles elimination. The national immunization campaign was conducted in phases by geographic region and combined multiple interventions to reach high coverage in all districts. Methods. We analyzed reported data on number of doses administered and results of rapid monitoring by "commune" (district) to evaluate coverage for each vaccine and intervention in target populations. We reviewed measles and rubella surveillance data from Haiti's national surveillance system. Results. Immunization registers recorded 4.7 million doses of measles-rubella (MR) vaccine administered to persons 1–19 years of age, reaching 80.2% of the estimated population of 1–4 year-olds and surpassing the target among 5–19 year-olds. In addition, 1 million children under 5 years of age received oral polio vaccine and vitamin A supplements, 1.5 million school children received deworming treatment nationwide, and over 500 000 women 15–49 years old in 2 major population centers received diphtheria-tetanus vaccine. Based on administrative data, 102 (76.7%) of 133 communes attained 95% or greater coverage with MR vaccine among persons 1–19 years of age. Rapid monitoring in 118 communes indicated that coverage targets were reached in 52.5%. From 2007 to 2010, no confirmed cases of measles or rubella were reported from Haiti. Conclusions. The experience in Haiti suggests that rubella and congenital rubella syndrome can be eliminated through mass vaccination in countries with weak national immunization programs. However, high routine immunization coverage and improved surveillance are urgently needed to maintain measles and rubella elimination.
AbstractList Background. Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles immunization campaign targeting persons 1–19 years of age to accelerate elimination of rubella and congenital rubella syndrome, while strengthening measles elimination. The national immunization campaign was conducted in phases by geographic region and combined multiple interventions to reach high coverage in all districts. Methods. We analyzed reported data on number of doses administered and results of rapid monitoring by "commune" (district) to evaluate coverage for each vaccine and intervention in target populations. We reviewed measles and rubella surveillance data from Haiti's national surveillance system. Results. Immunization registers recorded 4.7 million doses of measles-rubella (MR) vaccine administered to persons 1–19 years of age, reaching 80.2% of the estimated population of 1–4 year-olds and surpassing the target among 5–19 year-olds. In addition, 1 million children under 5 years of age received oral polio vaccine and vitamin A supplements, 1.5 million school children received deworming treatment nationwide, and over 500 000 women 15–49 years old in 2 major population centers received diphtheria-tetanus vaccine. Based on administrative data, 102 (76.7%) of 133 communes attained 95% or greater coverage with MR vaccine among persons 1–19 years of age. Rapid monitoring in 118 communes indicated that coverage targets were reached in 52.5%. From 2007 to 2010, no confirmed cases of measles or rubella were reported from Haiti. Conclusions. The experience in Haiti suggests that rubella and congenital rubella syndrome can be eliminated through mass vaccination in countries with weak national immunization programs. However, high routine immunization coverage and improved surveillance are urgently needed to maintain measles and rubella elimination.
Background.  Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles immunization campaign targeting persons 1-19 years of age to accelerate elimination of rubella and congenital rubella syndrome, while strengthening measles elimination. The national immunization campaign was conducted in phases by geographic region and combined multiple interventions to reach high coverage in all districts. Methods.  We analyzed reported data on number of doses administered and results of rapid monitoring by "commune" (district) to evaluate coverage for each vaccine and intervention in target populations. We reviewed measles and rubella surveillance data from Haiti's national surveillance system. Results.  Immunization registers recorded 4.7 million doses of measles-rubella (MR) vaccine administered to persons 1-19 years of age, reaching 80.2% of the estimated population of 1-4 year-olds and surpassing the target among 5-19 year-olds. In addition, 1 million children under 5 years of age received oral polio vaccine and vitamin A supplements, 1.5 million school children received deworming treatment nationwide, and over 500000 women 15-49 years old in 2 major population centers received diphtheria-tetanus vaccine. Based on administrative data, 102 (76.7%) of 133 communes attained 95% or greater coverage with MR vaccine among persons 1-19 years of age. Rapid monitoring in 118 communes indicated that coverage targets were reached in 52.5%. From 2007 to 2010, no confirmed cases of measles or rubella were reported from Haiti. Conclusions.  The experience in Haiti suggests that rubella and congenital rubella syndrome can be eliminated through mass vaccination in countries with weak national immunization programs. However, high routine immunization coverage and improved surveillance are urgently needed to maintain measles and rubella elimination.
BACKGROUNDPrior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles immunization campaign targeting persons 1-19 years of age to accelerate elimination of rubella and congenital rubella syndrome, while strengthening measles elimination. The national immunization campaign was conducted in phases by geographic region and combined multiple interventions to reach high coverage in all districts.METHODSWe analyzed reported data on number of doses administered and results of rapid monitoring by "commune" (district) to evaluate coverage for each vaccine and intervention in target populations. We reviewed measles and rubella surveillance data from Haiti's national surveillance system.RESULTSImmunization registers recorded 4.7 million doses of measles-rubella (MR) vaccine administered to persons 1-19 years of age, reaching 80.2% of the estimated population of 1-4 year-olds and surpassing the target among 5-19 year-olds. In addition, 1 million children under 5 years of age received oral polio vaccine and vitamin A supplements, 1.5 million school children received deworming treatment nationwide, and over 500000 women 15-49 years old in 2 major population centers received diphtheria-tetanus vaccine. Based on administrative data, 102 (76.7%) of 133 communes attained 95% or greater coverage with MR vaccine among persons 1-19 years of age. Rapid monitoring in 118 communes indicated that coverage targets were reached in 52.5%. From 2007 to 2010, no confirmed cases of measles or rubella were reported from Haiti.CONCLUSIONSThe experience in Haiti suggests that rubella and congenital rubella syndrome can be eliminated through mass vaccination in countries with weak national immunization programs. However, high routine immunization coverage and improved surveillance are urgently needed to maintain measles and rubella elimination.
Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles immunization campaign targeting persons 1-19 years of age to accelerate elimination of rubella and congenital rubella syndrome, while strengthening measles elimination. The national immunization campaign was conducted in phases by geographic region and combined multiple interventions to reach high coverage in all districts. We analyzed reported data on number of doses administered and results of rapid monitoring by "commune" (district) to evaluate coverage for each vaccine and intervention in target populations. We reviewed measles and rubella surveillance data from Haiti's national surveillance system. Immunization registers recorded 4.7 million doses of measles-rubella (MR) vaccine administered to persons 1-19 years of age, reaching 80.2% of the estimated population of 1-4 year-olds and surpassing the target among 5-19 year-olds. In addition, 1 million children under 5 years of age received oral polio vaccine and vitamin A supplements, 1.5 million school children received deworming treatment nationwide, and over 500000 women 15-49 years old in 2 major population centers received diphtheria-tetanus vaccine. Based on administrative data, 102 (76.7%) of 133 communes attained 95% or greater coverage with MR vaccine among persons 1-19 years of age. Rapid monitoring in 118 communes indicated that coverage targets were reached in 52.5%. From 2007 to 2010, no confirmed cases of measles or rubella were reported from Haiti. The experience in Haiti suggests that rubella and congenital rubella syndrome can be eliminated through mass vaccination in countries with weak national immunization programs. However, high routine immunization coverage and improved surveillance are urgently needed to maintain measles and rubella elimination.
Author Lacapère, François
Chamoulliet, Henriette
Danovaro-Holliday, M. Carolina
Magloire, Roc
Celestin, Elie-Pierre
Flannery, Brendan
Author_xml – sequence: 1
  givenname: François
  surname: Lacapère
  fullname: Lacapère, François
– sequence: 2
  givenname: Roc
  surname: Magloire
  fullname: Magloire, Roc
– sequence: 3
  givenname: M. Carolina
  surname: Danovaro-Holliday
  fullname: Danovaro-Holliday, M. Carolina
– sequence: 4
  givenname: Brendan
  surname: Flannery
  fullname: Flannery, Brendan
– sequence: 5
  givenname: Henriette
  surname: Chamoulliet
  fullname: Chamoulliet, Henriette
– sequence: 6
  givenname: Elie-Pierre
  surname: Celestin
  fullname: Celestin, Elie-Pierre
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21954269$$D View this record in MEDLINE/PubMed
BookMark eNqFkM1KxDAUhYMoOo4uXSrZ6cJqkpumzVIG_8AfEMdtyaTJmGEmqU0ruPMdfEOfxI4dZ-vicuDycTh8u2jTB28QOqDkjBIJ587b0sXzmat5TjbQgKaQJUJQ2EQDQhhLaC7lDtqNcUYI4SCybbTDqEw5E3KAyudXg8fR4GDxk6pciUfh3dRqavB98K4JtfNT7DxuOu5BNS54NcdP7cTM5wq_KK2d__3ikVpUyk39Kb5RrnGYEZJ9f351ke-hLavm0eyvcojGV5fPo5vk7vH6dnRxl2jIRZNYazJuqbJCTKxUpbagUmONAsI51ZYyoXJGIEvzic4plMCI4CB5KrLMUg1DdNz3VnV4a01sioWLernUm9DGIpcCJKTdDVHSk7oOMdbGFlXtFqr-KCgpll6L3mvRe-34o1VzO1mYck3_ieyAkx4IbfVv12GPzmKndw1zyoAIyOAHWsyONw
CitedBy_id crossref_primary_10_4269_ajtmh_13_0201
crossref_primary_10_1080_10810730_2014_939313
crossref_primary_10_1186_s12913_021_06995_z
crossref_primary_10_3390_vaccines10040567
crossref_primary_10_1111_tmi_12335
crossref_primary_10_1016_j_vaccine_2013_10_071
Cites_doi 10.1056/NEJMp1100118
10.1093/infdis/jir488
10.1590/S1020-49892004000300002
10.1590/S1020-49892004001200013
10.1590/S1020-49892002001000008
ContentType Journal Article
Copyright Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America
The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011
Copyright_xml – notice: Copyright © 2011 Oxford University Press on behalf of the Infectious Diseases Society of America
– notice: The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com 2011
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1093/infdis/jir480
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
DocumentTitleAlternate Rubella and Congenital Rubella Syndrome Elimination in the Americas
EISSN 1537-6613
EndPage S705
ExternalDocumentID 10_1093_infdis_jir480
21954269
10.1093/infdis/jir480
41230637
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Haiti
GeographicLocations_xml – name: Haiti
GroupedDBID ---
-DZ
-~X
..I
.2P
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABJS
AABMN
AABZA
AACGO
AACZT
AAESY
AAHTB
AAIYJ
AAJKP
AAJQQ
AAMVS
AANCE
AANRK
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AAUQX
AAVAP
AAWTL
ABBHK
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPTD
ABQLI
ABSAR
ABTLG
ABWST
ABXSQ
ABZBJ
ACGFO
ACGFS
ACGOD
ACIMA
ACPRK
ACUFI
ACUTO
ACYHN
ADBBV
ADEIU
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADORX
ADQLU
ADRIX
ADRTK
ADULT
ADVEK
ADYVW
ADZLD
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AIKOY
AIMBJ
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQVQM
ASMCH
AWCFO
AXUDD
AZQFJ
BAWUL
BAYMD
BCRHZ
BEYMZ
BGYMP
BHONS
BR6
BTRTY
BVRKM
BYORX
C45
CASEJ
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DNJUQ
DOOOF
DPORF
DPPUQ
DU5
DWIUU
D~K
EBS
ECGQY
EE~
EJD
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H5~
HAR
HW0
HZ~
IH2
IOX
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
W2D
W8F
WH7
X7H
YAYTL
YKOAZ
YXANX
ZA5
~91
.55
.GJ
3O-
41~
6.Y
AAHBH
AAPGJ
AARHZ
AASNB
AAUAY
AAWDT
AAYOK
ABNHQ
ABQNK
ABSMQ
ABXVV
ACFRR
ACMRT
ACPQN
ACUTJ
ACZBC
ADACV
ADQBN
AEKPW
AFHKK
AFSHK
AFYAG
AGKRT
AGMDO
AI.
APJGH
AQDSO
AQKUS
ATGXG
AVNTJ
BZKNY
EIHJH
G8K
H13
HQ3
HTVGU
IPSME
J5H
MBLQV
MVM
N4W
NEJ
O~Y
P0-
TMA
VH1
X7M
Y6R
ZE2
ZGI
ZKG
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c386t-ffe74f1af66bf9adcf3a5efea30441cf126a8203758bc813d320643945677f1c3
ISSN 0022-1899
IngestDate Fri Oct 25 05:21:35 EDT 2024
Thu Sep 12 18:17:18 EDT 2024
Tue Oct 15 23:45:46 EDT 2024
Wed Aug 28 03:23:48 EDT 2024
Fri Feb 02 08:15:51 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue suppl_2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c386t-ffe74f1af66bf9adcf3a5efea30441cf126a8203758bc813d320643945677f1c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/jid/article-pdf/204/suppl_2/S698/18067116/jir480.pdf
PMID 21954269
PQID 896393539
PQPubID 23479
ParticipantIDs proquest_miscellaneous_896393539
crossref_primary_10_1093_infdis_jir480
pubmed_primary_21954269
oup_primary_10_1093_infdis_jir480
jstor_primary_41230637
PublicationCentury 2000
PublicationDate 2011-09-01
PublicationDateYYYYMMDD 2011-09-01
PublicationDate_xml – month: 09
  year: 2011
  text: 2011-09-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2011
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Dietz ( key 20170702134421_bib7) 2004; 16
World Health Organization ( key 20170702134421_bib12)
Rainey ( key 20170702134421_bib6) 2011
World Health Organization ( key 20170702134421_bib1) 2000; 75
Pan American Health Organization ( key 20170702134421_bib2) 2009; 31
Centers for Disease Control and Prevention ( key 20170702134421_bib8) 2011; 59
Pan American Health Organization ( key 20170702134421_bib4) 2007; 29
Desinor ( key 20170702134421_bib5) 2004; 15
Golden ( key 20170702134421_bib3) 2002; 12
Dowell ( key 20170702134421_bib10) 2011; 364
Centers for Disease Control and Prevention ( key 20170702134421_bib9) 2011; 59
Pan American Health Organization ( key 20170702134421_bib11) 2010; 32
References_xml – volume: 364
  start-page: 300
  year: 2011
  ident: key 20170702134421_bib10
  article-title: Public health in Haiti–challenges and progress
  publication-title: N Engl J Med
  doi: 10.1056/NEJMp1100118
  contributor:
    fullname: Dowell
– year: 2011
  ident: key 20170702134421_bib6
  article-title: Haiti 2007–2008 national measles-rubella vaccination campaign: implications for rubella elimination
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jir488
  contributor:
    fullname: Rainey
– volume: 15
  start-page: 147
  year: 2004
  ident: key 20170702134421_bib5
  article-title: Seroprevalence of antibodies against rubella virus in pregnant women in Haiti
  publication-title: Rev Panam Salud Publica
  doi: 10.1590/S1020-49892004000300002
  contributor:
    fullname: Desinor
– volume: 75
  start-page: 161
  year: 2000
  ident: key 20170702134421_bib1
  article-title: Rubella vaccines: WHO position paper
  publication-title: Wkly Epidemiol Rec
  contributor:
    fullname: World Health Organization
– volume: 16
  start-page: 432
  year: 2004
  ident: key 20170702134421_bib7
  article-title: Assessing and monitoring vaccination coverage levels: lessons from the Americas
  publication-title: Rev Panam Salud Publica
  doi: 10.1590/S1020-49892004001200013
  contributor:
    fullname: Dietz
– volume-title: Improving immunization services in Haiti: partner support meeting. Global immunization Newsletter 2011
  ident: key 20170702134421_bib12
  contributor:
    fullname: World Health Organization
– volume: 12
  start-page: 269
  year: 2002
  ident: key 20170702134421_bib3
  article-title: Congenital rubella syndrome in Haiti (Short communication)
  publication-title: Rev Panam Salud Publica
  doi: 10.1590/S1020-49892002001000008
  contributor:
    fullname: Golden
– volume: 29
  start-page: 1
  year: 2007
  ident: key 20170702134421_bib4
  article-title: Haiti to launch a rubella and CRS elimination campaign on 5 November
  publication-title: Immunizations Newsletter
  contributor:
    fullname: Pan American Health Organization
– volume: 59
  start-page: 1673
  year: 2011
  ident: key 20170702134421_bib8
  article-title: Post-earthquake injuries treated at a field hospital—Haiti, 2010
  publication-title: MMWR Morb Mortal Wkly Rep
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 31
  start-page: 1
  year: 2009
  ident: key 20170702134421_bib2
  article-title: National campaign to eliminate rubella and strengthen measles elimination in Haiti
  publication-title: Immunizations Newsletter
  contributor:
    fullname: Pan American Health Organization
– volume: 59
  start-page: 939
  year: 2011
  ident: key 20170702134421_bib9
  article-title: Rapid establishment of an internally displaced persons disease surveillance system after an earthquake—Haiti, 2010
  publication-title: MMWR Morb Mortal Wkly Rep
  contributor:
    fullname: Centers for Disease Control and Prevention
– volume: 32
  start-page: 3
  year: 2010
  ident: key 20170702134421_bib11
  article-title: Haiti: vaccination campaign following the earthquake
  publication-title: Immunizations Newsletter
  contributor:
    fullname: Pan American Health Organization
SSID ssj0004367
Score 2.093998
Snippet Background. Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles...
Background.  Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles...
Prior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles immunization...
BACKGROUNDPrior to introduction of rubella vaccine in Haiti's national immunization program, the Haitian government conducted a nationwide rubella-measles...
SourceID proquest
crossref
pubmed
oup
jstor
SourceType Aggregation Database
Index Database
Publisher
StartPage S698
SubjectTerms Adolescent
Adult
Child
Child, Preschool
Communes
Communicable Disease Control
Congenital rubella syndrome
Haiti - epidemiology
Health Policy
Humans
Immunization
Infant
Mass immunization
Measles
Middle Aged
Oral poliovirus vaccine
Population estimates
Rubella
Rubella - epidemiology
Rubella - prevention & control
Rubella Vaccine - administration & dosage
Rubella Vaccine - immunology
Surveillance
THE ROLE OF RUBELLA ELIMINATION TOWARDS STRENGTHENING PRIMARY HEALTH CARE SERVICES
Vaccination
Young Adult
Title The Use of Rapid Coverage Monitoring in the National Rubella Vaccination Campaign, Haiti 2007–2008
URI https://www.jstor.org/stable/41230637
https://www.ncbi.nlm.nih.gov/pubmed/21954269
https://search.proquest.com/docview/896393539
Volume 204
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELbKIhAXBAu7lJeMhLgs6TZxaidHhFgqRDl0t6i3yHl4FYSaqtse4MR_4G_xK_glzHjspPuQWLhErRVHiefz-PN4Hoy9lFUOrFaVsMkxaRAbPQxyHcsgMkrE8UhFua3WMPkkx7P4w3w07_V-bXktbdb5oPh-ZVzJ_0gV2kCuGCX7D5JtHwoN8BvkC1eQMFyvLeMZGeOnelmXMLvhG9ALh6bqygWsWEdGb_WbbvCsQR981kVRky3wAE8gdH1qNdBY1-saMw0q7wgh0Hthm8V28WQu5QQ5dG3O_HlPS9Q_6kIv7WF8QsZuJMr2v2rq9q6JPv3aOCP5tCk66zlWbF01wRgzh5fa4mEyICcVV_absKexgBiVzEYfX4f4srPOpt6Y0QUXhAnVTBpUXierAGiE2FbaERUtdug8wwqoWbSliI8lFbd2i_qxssHdlxcMSqYFTSWmdDj6Uq9iqix1PjX3hSWzdWSkI3yR0QMy6n6D3YxA7aG-fT_vHI5iIZXPXY-f6DK-QvdD6n5I3c8xJHKSvRB9eWkTZMnQyT1218mevyFI3me9arHLblFd02-77PbEeWw8YCVghQNGeWO4xSj3GOUdRnm94IBR7jHKHUb5Fka5x-hrbhHKEaG_f_xEbD5ks6N3J2_HgavsERQikevAmErFJtRGytykuiyM0KPKVFoMgZ4XJoykBmoqYDObF0koSgA6Umdg-0qZsBB7bGfRLKpHjFelBo4qzNCkw9gkeRqmpVIyF4kyaT4SffbKj2a2pAQu2ZVS67M9O9btXXGI23Oh-uwFDP7fOnMvmgz0Mx666UUF8y5LYIVLxUikfbZPImufFGG2xUimj6_7ik_YnW7SPGU769WmegaceJ0_t1D7A7bathg
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Use+of+Rapid+Coverage+Monitoring+in+the+National+Rubella+Vaccination+Campaign%2C+Haiti+2007%E2%80%932008&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Lacap%C3%A8re%2C+Fran%C3%A7ois&rft.au=Magloire%2C+Roc&rft.au=Danovaro-Holliday%2C+M.+Carolina&rft.au=Flannery%2C+Brendan&rft.date=2011-09-01&rft.issn=0022-1899&rft.eissn=1537-6613&rft.volume=204&rft.issue=suppl_2&rft.spage=S698&rft.epage=S705&rft_id=info:doi/10.1093%2Finfdis%2Fjir480&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_infdis_jir480
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon